Sitryx
is an England-based biopharmaceutical company that researches and develops immune cell metabolism therapies for the treatment of chronic autoimmune diseases and cancer... Read moreSitryx
is an England-based biopharmaceutical company that researches and develops immune cell metabolism therapies for the treatment of chronic autoimmune diseases and cancer... Read more
News
Apr 10, 2024
GlobalNewswire
Press Release: Sitryx : Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
Mar 04, 2024
GlobalNewswire
Press Release: Sitryx : Sitryx Therapeutics makes key appointments to strengthen business operations and progress immunometabolism-targeting pipeline into clinical development
Jan 04, 2024
Yahoo
Sitryx: Sitryx announces collaboration partner Lilly has commenced a Phase 1 study of SIT-011 for chronic autoimmune and inflammatory diseases
Dec 21, 2022
PR Newswire
Press Release: Sitryx : SITRYX THERAPEUTICS ANNOUNCES PARTICIPATION AT THE LONGWOOD HEALTHCARE LEADERS PRE-JPM WEBCONFERENCE, JANUARY 5TH & JANUARY 6TH, 2023
Nov 10, 2022
PR Newswire
Press Release: Sitryx : Sitryx Therapeutics Announces Presentation at the Stifel 2022 Healthcare Conference
May 18, 2022
PR Newswire
Press Release: Sitryx : SITRYX THERAPEUTICS TO PARTICIPATE IN WELLS FARGO VIRTUAL PRIVATE BIOTECH SYMPOSIUM
Nov 10, 2021
StreetInsider
Press Release: Sitryx : Sitryx appoints Tanya E. Borsuk, Ph.D., as Chief Business Officer
Jul 06, 2021
MarketScreener
Sitryx: Sitryx licenses intellectual property rights for inhibitors of a new target in immunometabolism from Cancer Research UK in exclusive worldwide agreement
Mar 09, 2021
Commercial News Media
Sitryx: Second occupier for Bellhouse Building at The Oxford Science Park
Apr 03, 2020
SiliconRepublic
Sitryx: Biopharma firm with Irish link signs deal with Eli Lilly potentially worth $880m
Sitryx Competitors
1
2
3
4
5
6
7
8
9
10